3D-HAPPI: Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas

Sponsor
IHU Strasbourg (Other)
Overall Status
Completed
CT.gov ID
NCT03382327
Collaborator
(none)
136
12
1
36
11.3
0.3

Study Details

Study Description

Brief Summary

The aim of this study is to assess the benefit of 3D models in the planning of hepatic resection by comparing the changes in the surgical plan based on the analysis of conventional preoperative images (CT-scan and MRI), compared to the surgical plan based on the analysis of 3D reconstruction.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Surgical planning
N/A

Detailed Description

The detailed anatomical description of the liver described by Couinaud in 1954 is the basis for hepatic surgery. Surgical resection is the approach leading to the best survival rate in case of liver cancer. In hepatocarcinomas, systematic removal of the infected liver segment is considered the most effective technique to eliminate tumour, potential satellite nodules and avoid vascular spread. Resectability rate highly depends on the analysis of preoperative images. However, in 20% of cases, there are modifications compared with the initial surgical plan leading to an increase in morbidity rate.

In 2002, Couinaud highlighted the difficulty of identifying portal pedicles, especially because of anatomical variations, and recommended the use of a three-dimensional reconstruction from images provided by a helical scanner.

The hypothesis of the study is that 3D models would improve surgical planning leading to a decrease in intra-operative adjustments and mortality.

The aim of this multicentric, prospective study is to assess the benefit of 3D models in the surgical management of hepatocarcinomas, more specifically in the detailed analysis of 3D vascular structures and in the surgery planning with resection merges evaluation. The validation of this virtual method will be built on the comparison of the surgical plan based on the analysis of conventional preoperative images (CT-scan and MRI) and the surgical plan based on the analysis of 3D reconstruction.

Study Design

Study Type:
Interventional
Actual Enrollment :
136 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Multicentric Study Determining the Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas
Actual Study Start Date :
Oct 16, 2017
Actual Primary Completion Date :
Oct 16, 2020
Actual Study Completion Date :
Oct 16, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Surgical planning

Two surgical plans will be established preoperatively. The first plan will be based on standard preoperative images (CT-scan, MRI) review. The second plan will be based on the 3D model review.

Procedure: Surgical planning
Two surgical plans will be established preoperatively. The first plan will be based on standard preoperative images (CT-scan, MRI) review. The second plan will be based on the 3D model review. Both will be compared to the actual surgery performed in the operating room.

Outcome Measures

Primary Outcome Measures

  1. Comparison of the intra-operative modifications rates [At time of surgery]

    Modifications in the surgical planning compared to the plan based on the analysis of standard preoperative images (CT-scan and MRI) and the plan based on the 3D model analysis: changes in surgical resection type (by specifying the surgical act: tumorectomy, segmentectomy, bi-segmentectomy or lobectomy…) or no surgery.

Secondary Outcome Measures

  1. Comparison of tumor(s) location [At time of surgery]

    Comparison of tumor(s) location based on 3D model and standard preoperative images analysis.

  2. Comparison of vascular network anatomy [At time of surgery]

    Comparison of vascular network anatomy based on 3D model and standard preoperative images analysis.

  3. Choice of surgical plan [At time of surgery]

    Surgery done according to a) surgical plan based on standard preoperative images analysis, b) surgical plan based on 3D model analysis or c) alternative approach (by specifying the surgical act: tumorectomy, segmentectomy, bi-segmentectomy or lobectomy….)

  4. Modification of the initial surgical plan, if applicable [At time of surgery]

    Description of perioperative events having modified the initial surgical plan.

  5. Comparison of resection merges [At time of surgery]

    Comparison of expected resection merges based on standard preoperative images and 3D model analysis and actual resection merge in the operating room.

  6. Comparison of resection volumes [At time of surgery]

    Comparison of expected resection volumes based on standard preoperative images and 3D model analysis and actual resection volume in the operating room.

  7. Comparison of surgical merge size [At time of surgery]

    Comparison of surgical merge size (mm) based on 3D model and standard preoperative images analysis.

  8. Morbidity [At time of surgery and 3 months after surgery]

    Morbidity specific to the procedure.

  9. Mortality [At time of surgery and 3 months after surgery]

    Mortality specific to the procedure.

  10. Preoperative images independent analysis [3 years]

    Analysis of preoperative images (CT-scan/MRI and 3D model) by a senior team on one hand, and a junior team (surgeons + radiologists) on the other hand.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient with a hepatocarcinoma, eligible for surgical resection

  • Patient over 18 years old

  • Patient able to understand the study and provide written informed consent

  • Patient affiliated to the French social security system.

Exclusion Criteria:
  • Patient with other liver tumours

  • Patient whose general condition is not suitable for study participation (WHO ≥ 3)

  • Patient with a condition preventing its participation to study procedures, according to investigator's judgment

  • Patient with contraindications to injected CT-scan or MRI: allergic reaction to contrast agents, kidney failure, pacemaker, claustrophobia

  • Pregnancy or breastfeeding

  • Patient in exclusion period (determined by a previous study or in progress)

  • Patient in custody

  • Patient under guardianship.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service de Chirurgie Digestive - Hôpital Beaujon Clichy France 92112
2 Hôpital Henri Mondor - Service de Chirurgie Digestive et Hépatobiliaire - Créteil France 94010
3 Service de Chirurgie Digestive et Transplantation - Hôpital Claude Huriez Lille France 59037
4 Service de Chirurgie Digestive et Transplantation Hépatique - Hôpital universitaire de la Croix-Rousse Lyon France 69317
5 Service de Chirurgie Digestive - CH Emile Muller Mulhouse France 68100
6 Chirurgie Viscérale et Digestive - Polyclinique de Gentilly Nancy France 54100
7 Chirurgie Digestive, Hépato-bilio-pancréatique et Transplantation - La Pitié Sâlpêtrière Paris France 75013
8 Service de Chirurgie Digestive - CHU Robert Debré Reims France 51100
9 Service de Chirurgie Digestive Hôpital Charles Nicolle - CHU Rouen Rouen France 76000
10 Institut de Chirurgie Viscérale - Clinique de l'Orangerie Strasbourg France 67000
11 Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil Strasbourg France 67091
12 Centre Hépato-Biliaire - Hôpital Paul Brousse Villejuif France 94800

Sponsors and Collaborators

  • IHU Strasbourg

Investigators

  • Principal Investigator: Patrick Pessaux, MD, PhD, Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
IHU Strasbourg
ClinicalTrials.gov Identifier:
NCT03382327
Other Study ID Numbers:
  • 16-003
First Posted:
Dec 22, 2017
Last Update Posted:
Feb 10, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by IHU Strasbourg
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2021